35
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Emodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics

      review-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Emodin is a natural anthraquinone derivative that occurs in many widely used Chinese medicinal herbs, such as Rheum palmatum, Polygonum cuspidatum and Polygonum multiflorum. Emodin has been used as a traditional Chinese medicine for over 2000 years and is still present in various herbal preparations. Emerging evidence indicates that emodin possesses a wide spectrum of pharmacological properties, including anticancer, hepatoprotective, antiinflammatory, antioxidant and antimicrobial activities. However, emodin could also lead to hepatotoxicity, kidney toxicity and reproductive toxicity, particularly in high doses and with long‐term use. Pharmacokinetic studies have demonstrated that emodin has poor oral bioavailability in rats because of its extensive glucuronidation. This review aims to comprehensively summarize the pharmacology, toxicity and pharmacokinetics of emodin reported to date with an emphasis on its biological properties and mechanisms of action. Copyright © 2016 John Wiley & Sons, Ltd.

          Related collections

          Most cited references116

          • Record: found
          • Abstract: found
          • Article: not found

          Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction

          Severe acute respiratory syndrome (SARS) is an emerging infectious disease caused by a novel coronavirus (SARS-CoV). SARS-CoV spike (S) protein, a type I membrane-bound protein, is essential for the viral attachment to the host cell receptor angiotensin-converting enzyme 2 (ACE2). By screening 312 controlled Chinese medicinal herbs supervised by Committee on Chinese Medicine and Pharmacy at Taiwan, we identified that three widely used Chinese medicinal herbs of the family Polygonaceae inhibited the interaction of SARS-CoV S protein and ACE2. The IC50 values for Radix et Rhizoma Rhei (the root tubers of Rheum officinale Baill.), Radix Polygoni multiflori (the root tubers of Polygonum multiflorum Thunb.), and Caulis Polygoni multiflori (the vines of P. multiflorum Thunb.) ranged from 1 to 10 μg/ml. Emodin, an anthraquinone compound derived from genus Rheum and Polygonum, significantly blocked the S protein and ACE2 interaction in a dose-dependent manner. It also inhibited the infectivity of S protein-pseudotyped retrovirus to Vero E6 cells. These findings suggested that emodin may be considered as a potential lead therapeutic agent in the treatment of SARS.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Emodin inhibits current through SARS-associated coronavirus 3a protein

            The open-reading-frame 3a of SARS coronavirus (SARS-CoV) had been demonstrated previously to form a cation-selective channel that may become expressed in the infected cell and is then involved in virus release. Drugs that inhibit the ion channel formed by the 3a protein can be expected to inhibit virus release, and would be a source for the development of novel therapeutic agents. Here we demonstrate that emodin can inhibit the 3a ion channel of coronavirus SARS-CoV and HCoV-OC43 as well as virus release from HCoV-OC43 with a K 1/2 value of about 20 μM. We suggest that viral ion channels, in general, may be a good target for the development of antiviral agents.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Rhein: A Review of Pharmacological Activities

              Rhein (4, 5-dihydroxyanthraquinone-2-carboxylic acid) is a lipophilic anthraquinone extensively found in medicinal herbs, such as Rheum palmatum L., Cassia tora L., Polygonum multiflorum Thunb., and Aloe barbadensis Miller, which have been used medicinally in China for more than 1,000 years. Its biological activities related to human health are being explored actively. Emerging evidence suggests that rhein has many pharmacological effects, including hepatoprotective, nephroprotective, anti-inflammatory, antioxidant, anticancer, and antimicrobial activities. The present review provides a comprehensive summary and analysis of the pharmacological properties of rhein, supporting the potential uses of rhein as a medicinal agent.
                Bookmark

                Author and article information

                Journal
                Phytother Res
                Phytother Res
                10.1002/(ISSN)1099-1573
                PTR
                Phytotherapy Research
                John Wiley and Sons Inc. (Hoboken )
                0951-418X
                1099-1573
                18 May 2016
                August 2016
                : 30
                : 8 ( doiID: 10.1002/ptr.v30.8 )
                : 1207-1218
                Affiliations
                [ 1 ] School of Chinese Materia Medica Beijing University of Chinese Medicine Beijing 100102 PR China
                [ 2 ] Affiliated Hospital, Inner Mongolia University for Nationalities Tongliao 028000 PR China
                Author notes
                [*] [* ] Correspondence to: Jian Ni, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, PR China.

                E‐mail: njtcm@ 123456263.net

                [†]

                These authors contributed equally to this work.

                Article
                PTR5631 PTR-16-0009.R2
                10.1002/ptr.5631
                7168079
                27188216
                9bb8cbd3-0679-419c-83ba-562a0353e1f3
                Copyright © 2016 John Wiley & Sons, Ltd.

                This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

                History
                : 04 January 2016
                : 17 March 2016
                : 02 April 2016
                Page count
                Pages: 12
                Categories
                Review
                Reviews
                Custom metadata
                2.0
                August 2016
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.0 mode:remove_FC converted:15.04.2020

                Pharmacology & Pharmaceutical medicine
                emodin,pharmacology,toxicology,pharmacokinetics,mechanisms
                Pharmacology & Pharmaceutical medicine
                emodin, pharmacology, toxicology, pharmacokinetics, mechanisms

                Comments

                Comment on this article